The earnings call reflected a strong performance in revenue growth, particularly in consumables and bioprocessing solutions, along with successful product launches and strategic acquisitions. However, challenges remain in the equipment business, lab services, and tariff-related uncertainties. The overall sentiment is cautiously optimistic, with significant achievements in growth tempered by ongoing challenges.

Company Guidance -

Q3 2025

In the H1 2025 conference call for Sartorius and Sartorius Stedim Biotech, the company reported strong financial results with a revenue growth of 6% and underlying EBITDA increasing by 12% year-over-year, reaching a margin close to 30%. Bioprocessing Solutions saw a sales revenue rise of nearly 9%, primarily driven by consumables, despite softness in the equipment business. Lab Products & Services experienced a 4% decline in sales revenue, impacted by hesitance in larger capital investments. The acquisition of MatTek was completed, with contributions expected in H2. The company confirmed its full-year 2025 guidance, projecting group revenue growth of 6% and maintaining confidence in meeting these targets despite macroeconomic uncertainties. The call highlighted new product launches focused on enhancing drug development efficiency and sustainability, with promising customer feedback, further supporting their outlook.

Strong Revenue Growth

Revenue grew by 6% in constant currencies, with underlying EBITDA increasing by 12% year-over-year, bringing the EBITDA margin close to 30%.

Bioprocessing Solutions Performance

Bioprocessing Solutions sales revenue grew by nearly 9% year-over-year on a constant currency basis, driven by consumables.

New Product Launches

Launched new products in both divisions to enhance drug development and manufacturing, including a platform for incentivized bioprocesses developed in collaboration with Sanofi.

MatTek Acquisition

Closed the MatTek acquisition on July 1, expected to contribute to the division's financial results in the second half of the year.

Positive Free Cash Flow

Generated free cash flow, reducing leverage ratio as planned, with an operating cash flow of EUR 289 million.

Regional Performance

All regions reported solid growth, with the Americas showing the strongest growth in H1.

Sartorius (DE:SRT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

DE:SRT Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 16, 2025	2025 (Q3)	1.07 / -	0.21	―	―	―
Jul 22, 2025	2025 (Q2)	1.30 / 1.22	0.34	257.35% (+0.88)	―	―
Apr 16, 2025	2025 (Q1)	1.18 / 1.22	1.01	20.79% (+0.21)	―	―
Jan 28, 2025	2024 (Q4)	1.13 / 1.05	0.94	11.70% (+0.11)	―	―
Oct 17, 2024	2024 (Q3)	0.86 / 0.21	0.13	61.54% (+0.08)	―	―
Jul 18, 2024	2024 (Q2)	0.98 / 0.34	1.39	-75.54% (-1.05)	―	―
Apr 18, 2024	2024 (Q1)	1.10 / 1.01	1.69	-40.24% (-0.68)	―	―
Jan 26, 2024	2023 (Q4)	0.93 / 0.94	2.25	-58.22% (-1.31)	―	―
Oct 19, 2023	2023 (Q3)	1.34 / 0.13	2.45	-94.69% (-2.32)	―	―
Jul 21, 2023	2023 (Q2)	1.46 / 1.39	2.44	-43.03% (-1.05)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

DE:SRT Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 22, 2025	€166.20	€157.40	-5.29%
Apr 16, 2025	€161.40	€176.00	+9.05%
Jan 28, 2025	€197.76	€221.56	+12.03%
Oct 17, 2024	€179.04	€209.12	+16.80%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sartorius AG (DE:SRT) report earnings?

Sartorius AG (DE:SRT) is schdueled to report earning on Oct 16, 2025, Before Open (Confirmed).

What is Sartorius AG (DE:SRT) earnings time?

Sartorius AG (DE:SRT) earnings time is at Oct 16, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Sartorius AG stock?

The P/E ratio of Sartorius is N/A.

What is DE:SRT EPS forecast?

DE:SRT EPS forecast for the fiscal quarter 2025 (Q3) is 1.07.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing